No description available.

Immunomodulatory effects of lactic acid bacteria vary with strain and may vary with growth phase and medium. The ability of different lactobacilli strains (Lactobacillus helveticus R0052, L. rhamnosus R0011, L. rhamnosus GG) at different growth phases to modulate macrophage and intestinal epithelial cell cytokine production following a pro-inflammatory challenge was examined. Modulation of cytokine production by human macrophage cell lines (U-937) and intestinal epithelial cells (HT-29) induced by Tumor Necrosis Factor α was assayed by ELISA for interleukin-8 (IL-8). Granulocyte-macrophage colony stimulating factor (GM-CSF) production was assayed by ELISA in the HT-29 cell line. Strain-dependent differences were observed in the ability of viable bacteria and spent de Mann-Rogosa- Sharpe (MRS) broths from log versus stationary growth phase in HT-29 and U-937 cells. Overall, variation in the immunomodulatory activity of these lactic acid bacteria and spent broths reflects not only strain variation but potentially also differences in growth phase and substrate. / UOIT

No description available.

Inflammatory Bowel Diseases (IBD) result from the nexus of a genetic predisposition, dysregulated immunologic insult against commensal microflora, and an environmental trigger. The intestinal epithelium is a single cell layer that separates a highly active mucosal immune system from a large antigenic load in the intestinal lumen. Innate immune recognition combined with a highly regulated adaptive immune response maintains this tolerance. The intestinal epithelium in collusion with antigen presenting cells primarily modulates this activity. In this thesis, we show that, in response to DNA isolated from bacteria, innate toll like receptor 9 (TLR9) activation in intestinal epithelial cells modulates both arms of the immune system, to regulate intestinal homeostasis, and through this mechanism, Bifidobacteria breve DNA exerts its anti-inflammatory function. / Experimental Medicine

Serotonin (5-hydroxytryptamine, 5-HT) has been shown to activate carbohydrate metabolism in adult female Ascaris suum. Serotonin may be either absorbed directly from the environment or synthesized de novo from the absorbed L-tryptophan in adult female A. suum. The enzymes necessary for the synthesis of 5-HT have been identified in both intestine and muscle tissues. The serotonin absorbed from the environment is obtained either from the host's gastrointestinal contents or from the 5-HT producing bacteria in the intestine of A. suum. Numerous 5-HT producing bacteria were identified in the intestinal microflora. The physiological contributions of 5-HT producing bacteria to the 5-HT level, turnover and binding sites in the intestinal tissue of A. suum were investigated.

No description available.

Early innate response of intestinal epithelial cells is the first line defense against enteric pathogens. Toxoplasma gondii infections acquired naturally via the peroral route, encounter intestinal epithelial cells early post-infection. Although the population structure of T. gondii is known to be highly clonal, clinical strains of T. gondii have been classified into three genotypes based on their virulence. In this study we investigated whether human intestinal epithelial cell immune response to T. gondii is virulence dependent. We demonstrated distinct virulence of the three T. gondii genotype strains evaluated in human intestinal epithelial cells by their capacity to replicate and induce host cell cytotoxicity. The early host innate mechanisms such as activation of signaling pathways and induction of innate effectors were likewise differentially elicited by the three T. gondii strains. Low levels of TLR dependent NF-kB activation and a failure to rapidly up-regulate innate cytokine and chemokine genes was observed after virulent Type I strain infection. In contrast, early innate response to the less virulent Type II strain was rapid, efficient and led to high levels of IL-8 and IL-6 secretion, whereas response to Type III parasites was intermediate. Early expression of b-defensin 2 gene was suppressed specifically by virulent Type I strain and its activation prior to infection in intestinal epithelial cells led to decreased parasite viability. These findings provide evidence for T. gondii strain virulence dependent down-modulation of early human intestinal epithelial cell innate responses and highlight the importance of these cells in host defense against this infection.

京都大学 / 新制・課程博士 / 博士(医学) / 甲第24796号 / 医博第4988号 / 新制||医||1066(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 竹内 理, 教授 上野 英樹, 教授 椛島 健治 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

Changes in the human gastrointestinal microbiome are associated with several diseases. To infer causality, experiments in representative models are essential, but widely used animal models exhibit limitations. Here we present a modular, microfluidics-based model (HuMiX, human-microbial crosstalk), which allows co-culture of human and microbial cells under conditions representative of the gastrointestinal human-microbe interface. We demonstrate the ability of HuMiX to recapitulate in vivo transcriptional, metabolic and immunological responses in human intestinal epithelial cells following their co-culture with the commensal Lactobacillus rhamnosus GG (LGG) grown under anaerobic conditions. In addition, we show that the co-culture of human epithelial cells with the obligate anaerobe Bacteroides caccae and LGG results in a transcriptional response, which is distinct from that of a co-culture solely comprising LGG. HuMiX facilitates investigations of host-microbe molecular interactions and provides insights into a range of fundamental research questions linking the gastrointestinal microbiome to human health and disease.

Les bactéries commensales digestives jouent un rôle primordial dans l’homéostasie épithéliale et la santé de l’hôte, avec notamment un rôle modulateur du système immunitaire. Des effets bénéfiques dans le traitement des pathologies inflammatoires intestinales ont été caractérisés chez certaines souches de bactéries commensales. La compréhension de ces effets dans le maintien de l’homéostasie intestinale repose sur la connaissance des interactions entre les bactéries, l’épithélium intestinal et le système immunitaire muqueux. Streptococcus salivarius est l’un des premiers colonisateurs de la cavité buccale et du tractus digestif de l’homme. Cette bactérie a été utilisée comme modèle pour rechercher des mécanismes impliquée dans l’homéostasie.La recherche d’interactions entre des souches de l’espèce S. salivarius et les cellules humaines a été réalisée pour caractériser leurs éventuelles propriétés immunomodulatrices. Nous avons montré que les bactéries vivantes et les surnageants de cultures des souches de cette espèce modulent la réponse inflammatoire in vitro via un effet inhibiteur sur l’activation de la voie NF-B dans les cellules épithéliales intestinales (HT-29 et Caco-2) et les monocytes (THP-1). Cette modulation de l’inflammation a été confirmée par la capacité des surnageants bactériens à inhiber la sécrétion d’IL-8 par les cellules épithéliales. Ces surnageants agissent via une étape impliquant IB-, un inhibiteur du facteur NF-B. Ils inhibent la dégradation de la protéine IB- phosphorylée et diminuent ainsi la translocation nucléaire des composants NF-B. Nous avons également identifié et caractérisé un métabolite bactérien présent dans ces surnageants exerçant cette activité anti-inflammatoire. L’utilisation de ce métabolite et son isomère miment in vitro l’effet inhibiteur des surnageants sur l’activation de la voie NF-B dans les cellules épithéliales et les monocytes. Nous avons ainsi caractérisé un métabolite secrété par la bactérie commensale S. salivarius qui est capable d’inhiber une des voies centrales de signalisation impliquée dans la réponse inflammatoire intestinale. Enfin, une capacité anti-inflammatoire de S. salivarius a également été montrée dans un modèle murin d’inflammation digestive dans lequel les bactéries métaboliquement actives ont protégé les animaux de colites induites avec du TNBS. Ces travaux ouvrent la voie pour le développement d’applications thérapeutiques dans le traitement de pathologies inflammatoires de l’intestin basées sur ce composé actif ou l’utilisation de S. salivarius comme probiotique. / Commensal bacteria play a vital role in epithelial homeostasis and host health, including a modulatory role of the immune system. Their beneficial effects in the treatment of inflammatory bowel disease have been characterized in some strains of commensal bacteria. Understanding these effects in maintaining intestinal homeostasis is based on the knowledge of interactions among bacteria, the intestinal epithelium and the mucosal immune system. Streptococcus salivarius is one of the first colonizers of human oral cavity and digestive tract. This bacterium was used as a template to investigate mechanisms involved in homeostasis.The research for interactions between strains of S. salivarius species and human cells was performed to characterize their possible immunomodulatory properties. We have shown that living bacteria and culture supernatants of strains of this species modulate the inflammatory response in vitro via an inhibitory effect on the activation of NF-B in intestinal epithelial cells (HT-29 and Caco-2) and monocytes (THP-1). This modulation of inflammation was confirmed by the ability of bacterial supernatants to suppress the secretion of IL-8 by epithelial cells. These supernatants act via a step involving IκB-α, an inhibitor of NF-B. They inhibit the degradation of IκB-α phosphorylated protein and thus decrease the nuclear translocation of NF-B components. We also identified and characterized a bacterial metabolite present in these supernatants exercising this anti-inflammatory activity. Use of this metabolite and its isomer in vitro mimic the repressive effect of supernatants on activation of NF-B in epithelial cells and monocytes. We have characterized a metabolite secreted by commensal bacterium S. salivarius that is capable of inhibiting one of the central signaling pathways involved in the intestinal inflammatory response. Finally, an anti-inflammatory capacity of S. salivarius was also shown in a mouse model of gastrointestinal inflammation in which the metabolically active bacteria protected the animals from colitis induced with TNBS.This work paves way for the development of therapeutic applications in the treatment of inflammatory bowel disease based on the active compound or the use of S. salivarius as a probiotic.